COVID-19

Ultraviolet-C light makes benzalkonium chloride, which is found in many disinfectants, safer to use.

What happens in India, or anywhere else in the world, doesn't stay there. The longer COVID-19 hangs around, the more chance it has of mutating into a variant that the vaccines won't stop.

Between the trifecta of departments responsible for infection prevention—EVS, nursing and infection prevention—it’s every individual’s responsibility to ensure surface cleaning and disinfecting are done quickly and effectively.

During this time, as hospital case counts drop, IPs are expected to just switch back to normal while still ensuring a readiness to respond to COVID-19.

The truth is that variants will occur where the virus spreads and until SARS-CoV-2 is controlled everywhere, it won’t be controlled anywhere. What is occurring in India is a prime example of this.

Nurses need a seat at the table when discussing PPE stockpiling and purchasing practices to share their lived experiences and help the team discover where practice deviated from plans. Infection preventionists should support the nurses in these discussions as allies.

IPs and other health care professionals needed to improvise. That improvisation led to investigations into how many times an N95 can be reused and still keep SARS- CoV-2 at bay.

Individuals vaccinated against COVID-19 do not need to wear a mask outdoors when in small groups, when dining outside, or when biking or running, the CDC announced. However, face-covering precautions should still be taken in some settings.

MIT professors argue that many variables should be included when determining just how much social distancing is needed in different indoor settings.

Hospital employees performed hand hygiene under the gaze of infection preventionists, and the study data were gathered during the COVID-19 pandemic.

If you work in a health care facility, you need to be vaccinated against SARS-CoV-2. If you choose not to become vaccinated, then you should choose not to be working in a health care setting.

Though spring is in the air and we’re all anxious to get our old lives back, we’re not quite out of the COVID-19 woods yet.

Kaiser Family Foundation: “Federal, state, and local officials, and the private sector, will face the challenge of having to figure out how to increase willingness to get vaccinated among those still on the fence.”

Luke Daum, PhD: “With regards to testing in the US, no other country compares to us. We do a great job in all 50 states of testing, having turnaround testing for using qPCR collection for at-home, or through the drive-through centers at CVS or Walgreens.”

It’s important to match COVID-19 masking rules to reasoning behind them.

The risk of COVID-19 surface transmission is low, says the CDC, and is especially low outdoors.

Meri Pearson, MPH, CIC: “Infection preventionists still need to do those active audits to make sure that they’re actually seeing what’s happening at the bedside.”

The number of syphilis cases in 2000 raised hopes that it could be eradicated, but since 2015 cases have risen 74%.

Christina Yen, MD: “For any infection preventionists who are thinking about or are reviewing the need for VHP sometime in the future, just know that those colleagues that we’ve relied on this time around are going to be there and are going to be your partners in the VHP process.”

The lessons infection preventionists at the University of Mississippi Medical Center learned from an outbreak of respiratory illness at the facility’s NICU in 2019, were later used to help deal with the COVID-19 pandemic.

The infection prevention and business intelligence teams at Piedmont Healthcare put their heads together to streamline the process of tracking health care-acquired infections.

Joachim L. Schultze, MD: “We decided that the knowledge that we have in immunology, as well as in genomics and single-cell technology, should be used to understand this new disease.”

One thing that will haunt me and many health care personnel in both acute care and LTCFs forever is that so many people died without a family member at their bedside.

The CDC and FDA are expected to announce an immediate pause for administering the one-shot adenovirus Ad26.COV2.S while advising states distributing the product to consider doing the same.

Those fully vaccinated had 90% protection against infection regardless of symptoms and even partial immunization yielded 80% protection against infection.